In the last 12 months, insiders at Matinas BioPharma Holdings, Inc. ($MTNB) filed 23 transactions with the SEC: 6 open-market purchases totaling $1,687,000 and 0 sales totaling $0. Net insider sentiment: net buying.
Matinas BioPharma Holdings, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Sanitam Partners LLC (Not found) — 2 transactions totaling $703,000
- EIDE ROBERT J (Not found) — 2 transactions totaling $492,000
- Pembroke & Partners LLC (Not found) — 2 transactions totaling $492,000
- NEUGEBOREN EDWARD (Director) — 1 transaction totaling $0
- Kucinski Keith A (Chief Financial Officer) — 1 transaction totaling $0
View all SEC Filings for Matinas BioPharma Holdings, Inc. (MTNB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 30, 2025 | Smith Robin L | Director | A | Stock Option (right to Buy) | 11600 | $0.00 | 11,600.0000 | 5,086,985 | 9999.99% | 0.23% |
| April 30, 2025 | D An Evelyn | Director | A | Stock Option (right to Buy) | 11600 | $0.00 | 11,600.0000 | 5,086,985 | 9999.99% | 0.23% |
| April 30, 2025 | NEUGEBOREN EDWARD | Director | A | Stock Option (right to Buy) | 11600 | $0.00 | 11,600.0000 | 5,086,985 | 9999.99% | 0.23% |
| April 30, 2025 | Jabbour Jerome D | President and CEO | A | Stock Option (right to Buy) | 70100 | $0.00 | 70,100.0000 | 5,086,985 | 9999.99% | 1.38% |
| April 30, 2025 | Murphy Keith | Director | A | Stock Option (right to Buy) | 11600 | $0.00 | 11,600.0000 | 5,086,985 | 9999.99% | 0.23% |
| April 8, 2025 | Pembroke & Partners LLC | Not found | P | Warrants | 1679182 | $0.00 | 3,358,364.0000 | 5,086,985 | 100.00% | 33.01% |
| April 8, 2025 | Sanitam Partners LLC | Not found | P | Series C Convertible Preferred Stock | 703 | $1000.00 | 1,406.0000 | 5,086,985 | 100.00% | 0.01% |
| April 8, 2025 | Sanitam Partners LLC | Not found | P | Warrants | 2399318 | $0.00 | 4,798,636.0000 | 5,086,985 | 100.00% | 47.17% |
| April 8, 2025 | EIDE ROBERT J | Not found | P | Series C Convertible Preferred Stock | 492 | $1000.00 | 984.0000 | 5,086,985 | 100.00% | 0.01% |
| April 8, 2025 | EIDE ROBERT J | Not found | P | Warrants | 1679182 | $0.00 | 3,358,364.0000 | 5,086,985 | 100.00% | 33.01% |
| April 8, 2025 | Pembroke & Partners LLC | Not found | P | Series C Convertible Preferred Stock | 492 | $1000.00 | 984.0000 | 5,086,985 | 100.00% | 0.01% |
| Dec. 15, 2023 | Jabbour Jerome D | President and CEO | A | Stock Option (right to Buy) | 3500000 | $0.00 | 3,500,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | Ferguson James J. III | Chief Medical Officer | A | Stock Option (right to Buy) | 1200000 | $0.00 | 1,200,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | Matkovits Theresa | Chief Development Officer | A | Stock Option (right to Buy) | 1300000 | $0.00 | 1,300,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | Hoover Thomas | Chief Business Officer | A | Stock Option (right to Buy) | 1000000 | $0.00 | 1,000,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | Kucinski Keith A | Chief Financial Officer | A | Stock Option (right to Buy) | 1000000 | $0.00 | 1,000,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | Liu Hui | Chief Technology Officer | A | Stock Option (right to Buy) | 1000000 | $0.00 | 1,000,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2023 | Scibetta James S | Director | A | Stock option (right to buy) | 437244 | $0.00 | 437,244.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2023 | Giordano Natasha | Director | A | Stock option (right to buy) | 437244 | $0.00 | 437,244.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2023 | Ende Eric J | Director | A | Stock option (right to buy) | 437244 | $0.00 | 437,244.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2023 | Corzo Kathryn Penkus | Director | A | Stock option (right to buy) | 437244 | $0.00 | 437,244.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2023 | WIKLER MATTHEW | Director | A | Stock option (right to buy) | 437244 | $0.00 | 437,244.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2023 | CONRAD HERBERT J | Director | A | Stock option (right to buy) | 437244 | $0.00 | 437,244.0000 | 0 | 9999.99% | 0.00% |